title: [Advanced therapy: from European regulatory framework to national regulatory framework].
abstract: The European regulation n(o) 1394/2007/CE published on the 13th of November 2007 defined and harmonized the European regulatory framework for advanced therapy medicinal products. It creates a specialized committee located at the European Medicine Agency, in charge of the assessment of these medicinal products. The consequences of this regulation are introduced in the French regulation by the law n(o) 2011-302 published on the 22nd of March 2011. It detailed notably the possibility for public establishments (except health establishments) and nonprofit organisms to create pharmaceutical establishments. This law defined also a specific category of advanced therapy medicinal products, which fall under the "hospital exemption" framework. The rules regarding the authorizations of the establishments able to prepare these types of medicinal products and the authorization of the products are defined by the n(o) 2012-1236 decree published on the 6th of November 2012.
authors.affiliation: Agence nationale de sécurité du médicament, 143-147, boulevard Anatole-France, 93285 Saint-Denis, France. sophie.lucas-samuel@ansm.sante.fr
authors.forename: S
authors.initials: S
authors.lastname: Lucas-Samuel
mesh_terms: D002568:Certification / Q000331:legislation & jurisprudence; D004339:Drug Compounding; D004345:Drug Industry / Q000331:legislation & jurisprudence; D015507:Drugs, Investigational; D005062:European Union; D005602:France; D006801:Humans; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug; D060735:Pharmacovigilance; D010607:Pharmacy Service, Hospital / Q000331:legislation & jurisprudence; D057285:Precision Medicine; D035703:Therapies, Investigational
chemical_list: D015507:Drugs, Investigational